Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-5.31%EBITDA Margin
VS
Market
Sector
Industry
History
$ 1.04Close
$ 0.72 - $ 1.6 52-Week Range
Ticker Information
Ticker
TXMDCompany Name
THERAPEUTICSMD INCSector
HealthcareIndustry
Drug Manufacturers - Specialty & GenericExchange
NASDAQTHERAPEUTICSMD INC - EBITDA Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
TXMD - EBITDA % Historical data
| Date | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | EBITDA Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ -136K | -5.31% | $ 2.56M |
| 3/31/2025 | $ -1.69M | -91.8% | $ 1.84M |
| 12/31/2024 | $ -1.7M | -96.71% | $ 1.76M |
| 9/30/2024 | $ -2.42M | -151.63% | $ 1.6M |
| 6/30/2024 | $ -5.14M | -515.96% | $ 996K |
| 3/31/2024 | $ -6.47M | -539.95% | $ 1.2M |
| 12/31/2023 | $ -9.4M | -721.89% | $ 1.3M |
| 9/30/2023 | $ 35.49M | 1818.03% | $ 1.95M |
| 6/30/2023 | $ 15.36M | 67.01% | $ 22.92M |
| 3/31/2023 | $ 143.17M | 280.48% | $ 51.05M |
Key Performance Insights, Last 5 Years
- THERAPEUTICSMD INC's latest trailing twelve months (TTM) EBITDA % stands at -272.85%.
- Over the past 5 years, THERAPEUTICSMD INC's average EBITDA % has been -51%.
- The median EBITDA % for THERAPEUTICSMD INC during this period was -142.72%
- THERAPEUTICSMD INC reached its highest EBITDA % over the past 5 years at 1818.03%.
- The lowest EBITDA % recorded by THERAPEUTICSMD INC in the same timeframe -721.89%
THERAPEUTICSMD INC's EBITDA % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBITDA % Benchmarks
Similar metrics to Revenues:
- EBIT Margin - [Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Free Cash Flow Margin - [Calculation] A company’s Free Cash Flow [FCF] as a percentage of [Revenue]. Measures how much cash a company produces for each dollar of revenue generated.
- Enterprise Value over EBITDA - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest, taxes, depreciation, and amortization [EBITDA].
- Revenues - [Income Statement] The sum of revenue generated from all sold goods and rendered services.
Definition of EBITDA Margin
[Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.EBITDA / Revenues
(=) EBITDA % EBITDA % for THERAPEUTICSMD INC is calculated as follows: EBITDA [ $ -158.79M ] / Revenues [ $ 58.2M ]
(=) EBITDA % [ -272.85% ] TXMD - EBITDA Margin, Last 5 years
-721.89%
Minimum
Dec 31, 2023
1818.03%
Maximum
Sep 30, 2023
-51%
Average
-142.72%
Median
EBITDA % Benchmark AnalysisMarket
The chart above depicts the distribution of EBITDA % for companies in the Total Stock Market. The average EBITDA % of the companies is 16.2% with a standard deviation of 26.73%.
The following table provides additional summary stats:
EBITDA % in the Market:
| filtered constituents | 3.29K |
|---|---|
| min | -74.33% |
| max | 97.24% |
| average | 16.2% |
| median | 14.74% |
| std | 26.73% |